» Articles » PMID: 18792986

Genotype-phenotype Correlations in Rubinstein-Taybi Syndrome

Overview
Specialty Genetics
Date 2008 Sep 17
PMID 18792986
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Rubinstein-Taybi syndrome (RTS) is a rare multiple congenital anomaly/intellectual impairment syndrome. Loss of function in CREBBP or EP300 genes has been found in about 50% of patients with RTS. Genotype-phenotype correlations were investigated in 93 patients meeting diagnostic criteria for RTS during 2 international RTS family conferences. Mutation analysis of CREBBP was performed on all 31 coding exons and exon-intron junctions; a subset of patients had FISH analysis for large deletions. A total of 64 different variations were observed in the DNA sequence, and determined to be definitive mutations in 52 patients (56%). Mutations detected included: 10 missense mutations; 36 truncating or splice-site mutations; and 6 large deletions detectable by FISH. Fourteen patients had synonymous changes of unknown significance. The majority of mutations affected the HAT domain of CREBBP or predicted termination of the protein before the HAT region. Extensive phenotypic data were collected on each patient and analyzed to determine correlations with mutation types, that is, truncating, large deletions, single amino acid substitutions, or no CREBBP mutation. All four groups displayed the characteristic facial and thumb dysmorphology. Growth retardation in height and weight was seen more frequently in patients with no CREBBP mutation; seizure disorder was more frequent in those with CREBBP mutations. Degree of mental retardation was similar in all groups, although there was a trend toward lower IQ and autistic features in patients with large deletions. Similarity in phenotype between the groups implies that the several genes involved in causing RTS likely have effects through the same pathway.

Citing Articles

Molecular genetic analysis of Rubinstein-Taybi syndrome in Russian patients.

Ismagilova O, Adyan T, Beskorovainaya T, Polyakov A Front Genet. 2025; 16:1516565.

PMID: 39958159 PMC: 11825781. DOI: 10.3389/fgene.2025.1516565.


Epigenetics in rare neurological diseases.

Roberts C, Arezoumand K, Kadar Shahib A, Davie J, Rastegar M Front Cell Dev Biol. 2024; 12:1413248.

PMID: 39108836 PMC: 11300358. DOI: 10.3389/fcell.2024.1413248.


Identification of 22q11.2 deletion in a patient with schizophrenia and clinically diagnosed Rubinstein-Taybi syndrome.

Nagai Y, Nishioka M, Tanaka T, Shimano T, Kirino E, Suzuki T PCN Rep. 2024; 1(3):e34.

PMID: 38868697 PMC: 11114328. DOI: 10.1002/pcn5.34.


Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement.

Lacombe D, Bloch-Zupan A, Bredrup C, Cooper E, Douzgou Houge S, Garcia-Minaur S J Med Genet. 2024; 61(6):503-519.

PMID: 38471765 PMC: 11137475. DOI: 10.1136/jmg-2023-109438.


Exploring genotype-phenotype correlations in CREBBP: comment on the literature and description of an additional patient with an atypical outcome.

Vincent K, Graham G Eur J Hum Genet. 2023; 31(9):975-976.

PMID: 37246193 PMC: 10474082. DOI: 10.1038/s41431-023-01385-x.